Suppr超能文献

穿透性角膜移植术后的长期移植物存活情况。

Long-term graft survival after penetrating keratoplasty.

作者信息

Thompson Robert W, Price Marianne O, Bowers Patrick J, Price Francis W

机构信息

Price Vision Group, Indianapolis, Indiana, USA.

出版信息

Ophthalmology. 2003 Jul;110(7):1396-402. doi: 10.1016/S0161-6420(03)00463-9.

Abstract

PURPOSE

To determine long-term graft survival rates and causes of secondary graft failures for a large series of penetrating keratoplasties (PKPs).

DESIGN

Retrospective, noncomparative case series.

PARTICIPANTS

Longitudinal review of 3992 consecutive eyes that underwent PKP at a large tertiary care referral center from 1982 through 1996. Data were collected retrospectively from August 1982 through December 1988 and prospectively thereafter.

INTERVENTION

Three thousand six hundred forty primary grafts and 352 regrafts.

MAIN OUTCOME MEASURES

Corneal graft survival and etiology of graft failures. Patients were evaluated preoperatively and at 1, 3, 6, 9, 12, 18, and 24 months after transplant, then at yearly intervals.

RESULTS

Mean recipient age was 67 years (range, 1-98 years). The predominant indications for PKP were pseudophakic bullous keratopathy (32%) and Fuchs' dystrophy (23%). Graft failure occurred in 10% (385) of the eyes. The most common causes of secondary graft failure were endothelial failure (29%) or immunologic endothelial rejection (27%). Survival of first time grafts was 90% at 5 years and 82% at 10 years. Initial regrafts had significantly lower 5-year and 10-year survival rates, 53% and 41%, respectively. The highest 5-year and 10-year survival rates were noted in primary grafts for eyes with a preoperative diagnosis of keratoconus (97% and 92%, respectively), or Fuchs' dystrophy (97% and 90%, respectively). Primary grafts for aphakic bullous keratopathy without intraocular lens placement had the lowest 5-year survival rate, 70%.

CONCLUSIONS

The 5-year and 10-year survival rates in this series demonstrate that PKP is a safe and effective treatment for the corneal diseases commonly transplanted in the United States. However, endothelial failure and immunologic graft rejection were persistent risks over the long term, supporting the need for continued patient follow-up. Regrafts, aphakic eyes without intraocular lens placement at the time of transplant, and corneas with deep stromal vascularization had reduced graft survival rates. Pseudophakic bullous keratopathy grafts with a retained posterior chamber intraocular lens were at increased risk of endothelial failure compared with primary grafts done for other causes or compared with pseudophakic bullous keratopathy grafts done with intraocular lens exchange.

摘要

目的

确定大量穿透性角膜移植术(PKP)的长期移植存活率及二次移植失败的原因。

设计

回顾性、非对照病例系列研究。

参与者

对1982年至1996年在一家大型三级医疗转诊中心连续接受PKP的3992只眼睛进行纵向评估。数据于1982年8月至1988年12月进行回顾性收集,此后进行前瞻性收集。

干预措施

3640例初次移植和352例再次移植。

主要观察指标

角膜移植存活率及移植失败的病因。对患者在术前、移植后1、3、6、9、12、18和24个月进行评估,之后每年评估一次。

结果

受者平均年龄为67岁(范围1 - 98岁)。PKP的主要适应证为人工晶状体眼大泡性角膜病变(32%)和富克斯角膜内皮营养不良(23%)。10%(385只)的眼睛发生了移植失败。二次移植失败最常见的原因是内皮功能衰竭(29%)或免疫性内皮排斥反应(27%)。初次移植的5年存活率为90%,10年存活率为82%。初次再次移植的5年和10年存活率显著较低,分别为53%和41%。术前诊断为圆锥角膜或富克斯角膜内皮营养不良的初次移植眼睛的5年和10年存活率最高(分别为97%和92%,以及97%和90%)。未植入人工晶状体的无晶状体眼大泡性角膜病变的初次移植5年存活率最低,为70%。

结论

本系列研究中的5年和10年存活率表明,PKP是美国常见角膜疾病的一种安全有效的治疗方法。然而,内皮功能衰竭和免疫性移植排斥反应长期存在风险,这支持了对患者持续随访的必要性。再次移植、移植时未植入人工晶状体的无晶状体眼以及有深层基质血管化的角膜移植存活率降低。与因其他原因进行的初次移植或进行人工晶状体置换的人工晶状体眼大泡性角膜病变移植相比,保留后房型人工晶状体的人工晶状体眼大泡性角膜病变移植发生内皮功能衰竭的风险增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验